Shortage continues

TGA warns of continuing shortages of an arthritis treatment, but says the situation may be easing The Therapeutic Goods Administration (TGA) says there may be some light at the end of the tunnel with regard to the continuing supply issues around tocilizumab (Actemra). Despite the manufacturer, Roche, advising of ongoing shortages of the arthritis medication,